24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Biotech
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:32
Full list of Israeli startup M&As in 2024
19:46
Full list of Israeli high-tech funding rounds in 2024
17:57
Agora nets $34 million Series B for real estate investment management platform
16:33
Blackstone acquires Israel’s Priority Software at an $800 million valuation
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
2
The 50 most promising Israeli startups - 2024
3
Blackstone acquires Israel’s Priority Software at an $800 million valuation
4
Moritz code: Inside the mind of the best VC investor ever
5
Israel's Generative AI expansion: A 2024 market overview
More news
Biotech
20 stories about Biotech
Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas
12.11.18
|
Lilach Baumer
Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes
Biotech Company Polypid Raises $15 Million
07.11.18
|
Lilach Baumer
Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body
Kadimastem Gets FDA Orphan Drug Designation for ALS Drug
04.11.18
|
Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
Israel to Help Biotech Companies Go from Research to Manufacturing
04.11.18
|
Omri Milman
Companies looking to set up manufacturing facilities could receive grants covering 20%-30% of the costs
Former Teva Executives Raise $60 Million for Metabolic Disorders Venture
28.10.18
|
Lilach Baumer
The company’s pipeline of biologic and small molecule drug candidates was acquired from Teva
Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO
28.10.18
|
Lilach Baumer
The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share
Global Licensing and Commercialization Deal Catapults Collplant on Nasdaq
22.10.18
|
Lilach Baumer
The tissue regeneration company announced on Monday a deal with biotech company United Therapeutics and is currently up over 60% in pre-market trading
LogicBio Therapeutics Underperforms with $70 Million Nasdaq IPO
21.10.18
|
Lilach Baumer
Co-founded by Israel-born Adi Barzel, LogicBio develops genome-editing treatments for rare diseases
Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million
18.10.18
|
Lilach Baumer
The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms
Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO
30.09.18
|
Dror Reich
The Jerusalem-based company develops cellular and immune therapies. Its lead product is a universal bone marrow transplant solution
Automated Blood Tests Startup MeMed Raises $70 Million to Expand Offering
20.09.18
|
Omer Kabir
The company will use the funding to launch a new model of its blood testing device, and to expand the range of tests it offers
Antiseptic Materials Startup Nobio Raises $3.6 Million
30.07.18
|
Asaf Shalev
The Israel-based startup plans to target the dental and medical device industry, offering technology to solve the infection and contamination when devices are placed in the body.
Cancer Screening Company Nucleix Raises 2.5 Million Euros
30.07.18
|
Lilach Baumer
Founded in 2008, Nucleix develops urine and blood-based non-invasive, molecular cancer screening tests
Eli Lilly Signs Multi-Year Collaboration with Anima Biotech
23.07.18
|
Lilach Baumer
Israel-based Anima will receive an upfront payment of $30 million and $14 million for research, but could potentially get as much as $1.05 billion in milestones
Evogene Signs Brazilian Partnership to Develop Pest-Resistant Cotton
18.07.18
|
Lilach Baumer
Israel-based Evogene will identify pest-resistant genes in cotton, and Brazilian crop research Instituto Mato-Grossense do Algodão will test their effectiveness
NewStem, Which Screens Patients for Resistance to Chemotherapy, Raises $2 Million
16.07.18
|
Asaf Shalev
The Jerusalem-based startup is creating a proprietary database of mutated genes that cause resistance to different types of chemotherapeutic agents
Gene Discovery Startup Announces Breakthrough on Drought-Tolerant Crops
09.07.18
|
Asaf Shalev
Israel’s PlantArcBio has isolated the genes that help desert organisms survive. Now, the University of Wisconsin-Madison will test the genes’ impact on soybean yields
Three Portfolio Companies of Len Blavatnik's Clal Biotechnology Raise Cash in One Week
04.07.18
|
CTech
Clal Biotechnology Industries is an Israel-based life sciences investment company
Fourth Time’s the Charm for Entera Bio IPO
01.07.18
|
Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
Ben Gurion University Launches $1 Million Investment Fund
23.05.18
|
Hagar Ravet
The fund will invest in technologies developed and conceived by BGU students and graduates in the fields of technology, biotech, and social engagement
Previous Articles
More Articles
Please ensure Javascript is enabled for purposes of
website accessibility
